한글목차

세계 제대혈 보존 시장의 미래는 질병 치료 시장 및 의료 시장에서의 기회로 인해 유망할 것으로 예상됩니다. 세계 제대혈 보존 시장은 2025년부터 2031년까지 6.8%의 CAGR로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 줄기세포 치료에 대한 인식 개선, 맞춤형 의료 솔루션의 도입 확대, 장기 의료 보존에 대한 수요 증가 등이 있습니다.

• Lucintel의 예측에 따르면, 유형별로는 장기 보존이 예측 기간 동안 높은 성장률을 보일 것으로 예상됩니다.
• 용도별로는 질병 치료 분야가 더 높은 성장률을 보일 것으로 예상됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

제대혈 보존 시장의 새로운 동향

제대혈 보존 시장은 제대혈의 의학적 이점에 대한 인식 증가, 기술 발전, 재생의료 분야에서의 응용 확대 등을 배경으로 빠르게 성장하고 있습니다. 보호자와 의료진이 다양한 질병 치료에서 제대혈의 잠재력을 인식함에 따라, 혁신적인 보존 솔루션과 규제적 지원으로 시장은 계속 진화하고 있습니다. 이러한 발전은 안전, 접근성, 기술 통합을 중시하는 경쟁 구도를 형성하고 있습니다. 아래 주요 동향은 이 시장에 영향을 미치는 주요 변화를 강조하며, 보다 광범위한 보급과 환자 결과 개선을 위한 궤적을 반영하고 있습니다.

• 인식 및 채택 확대 : 제대혈 보존의 의학적 이점에 대한 일반인 및 의료진의 인식이 높아지면서 시장 성장을 견인하고 있습니다. 제대혈 인식개선 캠페인과 제대혈을 이용한 치료 성공사례는 더 많은 보호자들이 제대혈 보존을 선택할 수 있는 동기를 부여하고 있습니다. 이러한 추세는 백혈병, 빈혈, 면역질환 등의 치료에서 제대혈의 가능성을 보여주는 임상연구의 확대에 의해 뒷받침되고 있습니다. 그 결과, 민간 및 공공 은행 서비스에 대한 수요가 증가하여 제대혈 보존이 주류 의료 관행으로 자리 잡고 있습니다.
• 보존 및 처리 기술의 발전 : 냉동 보존 기술과 처리 방법의 혁신으로 보존된 제대혈의 생존율과 보존 기간이 향상되고 있습니다. 개선된 방법은 동결 및 해동 시 세포 손상을 줄여 이식 성공률을 높였습니다. 자동 처리 시스템과 개선된 저장 용기도 오염 위험을 줄였습니다. 이러한 기술 발전으로 인해 제대혈 은행은 더욱 신뢰할 수 있고 비용 효율적이며, 더 많은 가족과 의료 서비스 제공자가 보존 솔루션에 투자하도록 장려하고 있습니다.
• 치료 응용 범위 확대 : 제대혈로 치료할 수 있는 질환의 범위는 혈액질환을 넘어 신경질환, 뇌성마비, 당뇨병 등 재생의료 응용을 포함합니다. 줄기세포 연구의 발전은 새로운 치료 가능성을 개척하고 있으며, 이는 보존된 제대혈의 수요를 더욱 증가시키고 있습니다. 이러한 확대는 투자를 유치하고, 생명공학 기업과 의료 기관 간의 협력을 촉진하여 시장 성장을 더욱 가속화하고, 제대혈의 사용 사례를 다양화하고 있습니다.
• 규제 프레임워크 및 표준화 : 각국 정부와 규제 기관은 제대혈 은행의 안전, 품질, 윤리적 관행을 보장하기 위해 보다 명확한 가이드라인과 기준을 마련하고 있습니다. 이러한 규제는 소비자의 신뢰 구축과 국제 협력 촉진에 기여합니다. 처리 및 저장 프로토콜의 표준화는 은행 간 일관성을 보장하고 임상적 성공에 필수적입니다. 강화된 규제 모니터링은 보다 신뢰할 수 있는 시장 환경을 조성하고, 더 많은 가족들이 안전하고 신뢰할 수 있는 대안으로 제대혈 은행을 고려하도록 유도하고 있습니다.
• 투자 확대 및 시장 경쟁 심화 : 시장에서는 서비스 및 기술 역량 확대를 위한 사모펀드, 생명공학 기업, 의료 서비스 제공자의 투자가 증가하고 있습니다. 이 자본 유입은 혁신, 인프라 구축, 마케팅 활동을 촉진하고 있습니다. 서비스 제공자 간의 경쟁은 가격 책정, 서비스 품질, 고객 참여 전략의 개선으로 이어지고 있습니다. 그 결과, 시장은 신규 진입자와 서비스 제공 확대에 따라 더욱 역동적으로 변화할 것이며, 궁극적으로 소비자는 더 나은 접근성과 선택권을 통해 혜택을 누릴 수 있게 될 것입니다.

요약하면, 이러한 추세는 제대혈 보존 시장을 보다 혁신적이고 신뢰할 수 있으며 접근하기 쉬운 시장으로 변화시키고 있습니다. 인지도 향상, 기술 발전, 치료 용도 확대, 규제 지원 및 투자 유입이 지속적인 성장을 견인하고 있습니다. 이러한 발전은 시장 규모를 확대할 뿐만 아니라 제대혈 은행의 품질과 안전성을 향상시켜 현대 의료 및 재생의료의 중요한 구성요소로 자리매김하고 있습니다.

제대혈 보존 시장의 최근 동향

제대혈 보존 시장은 줄기세포 치료에 대한 인식 개선, 기술 발전, 재생의료 분야에서의 적용 확대에 힘입어 괄목할 만한 성장을 거듭하고 있습니다. 의료 제공자와 소비자가 다양한 질병 치료에서 제대혈의 잠재력을 인식함에 따라 시장은 빠르게 진화하고 있습니다. 채취, 처리, 보존 기술의 혁신으로 보존된 제대혈의 생존율과 안전성이 향상되고 있습니다. 또한, 규제 프레임워크와 파트너십이 시장 역학을 형성하고 있습니다. 이러한 발전은 시장의 성장, 접근성 및 전반적인 상황에 영향을 미치며, 생명공학 및 의료 분야 전반에 걸쳐 중요한 영역이 되고 있습니다.

• 기술 발전 : 처리 기술과 냉동 보존 기술의 향상으로 보존된 제대혈의 생존율과 보존 기간이 연장되어 소비자와 의료 제공자의 신뢰가 높아지고 있습니다. 이러한 혁신은 오염 위험을 줄이고 세포 회수율을 향상시킴으로써 치료 결과를 개선하고 시장 범위를 확대하는 데 기여하고 있습니다.
• 규제 발전 : 각국 정부와 규제기관은 제대혈 은행의 안전성, 품질, 윤리 기준을 보장하기 위해 보다 명확한 가이드라인을 마련하고 있습니다. 이러한 규제는 소비자의 신뢰를 높이고 국제적인 협력을 촉진하여 시장의 확대와 표준화를 촉진하고 있습니다.
• 인식 및 채택 확대 : 제대혈 줄기세포의 치료 가능성에 대한 부모와 의료 전문가들의 인식이 높아지면서 채취율이 증가하고 있습니다. 특히 신흥시장에서는 인식개선 활동과 성공사례가 수요를 견인하고 있으며, 시장 확대에 기여하고 있습니다.
• 전략적 제휴 및 합병 : 주요 생명공학 기업 및 병원들은 서비스 제공 및 연구 역량 강화를 위해 제대혈 은행과의 제휴를 추진하고 있습니다. 이러한 협력 관계는 혁신을 촉진하고, 인프라를 개선하며, 시장 침투율을 높이고, 산업 전반의 성장을 촉진하고 있습니다.
• 적용 범위 확대 : 제대혈의 활용 범위는 조혈모세포 이식을 넘어 재생의료, 자가면역질환, 맞춤형 치료로 확대되고 있습니다. 이러한 다각화는 새로운 투자자를 끌어들이고 시장 규모를 확대시키고 있으며, 향후 성장 전망은 매우 유망합니다.

요약하면, 기술 혁신, 규제 명확화, 인지도 향상, 전략적 제휴, 응용 범위 확대 등의 최근 동향이 결합하여 제대혈 보존 시장을 발전시키고 있습니다. 이러한 요인들은 시장의 안정성을 높이고, 접근성을 확대하며, 혁신을 촉진하여 궁극적으로 의료 및 생명공학 분야의 견고한 성장 궤도를 뒷받침하는 데 도움이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 업계 성장 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 제대혈 보존 시장 : 종류별

• 매력 분석 : 종류별
• 장기 보존
• 단기 보존

제5장 세계의 제대혈 보존 시장 : 용도별

• 매력 분석 : 용도별
• 질환 치료
• 의료

제6장 지역 분석

제7장 북미의 제대혈 보존 시장

• 북미의 제대혈 보존 시장 : 종류별
• 북미의 제대혈 보존 시장 : 용도별
• 미국의 제대혈 보존 시장
• 멕시코의 제대혈 보존 시장
• 캐나다의 제대혈 보존 시장

제8장 유럽의 제대혈 보존 시장

• 유럽의 제대혈 보존 시장 : 종류별
• 유럽의 제대혈 보존 시장 : 용도별
• 독일의 제대혈 보존 시장
• 프랑스의 제대혈 보존 시장
• 스페인의 제대혈 보존 시장
• 이탈리아의 제대혈 보존 시장
• 영국의 제대혈 보존 시장

제9장 아시아태평양의 제대혈 보존 시장

• 아시아태평양의 제대혈 보존 시장 : 종류별
• 아시아태평양의 제대혈 보존 시장 : 용도별
• 일본의 제대혈 보존 시장
• 인도의 제대혈 보존 시장
• 중국의 제대혈 보존 시장
• 한국의 제대혈 보존 시장
• 인도네시아의 제대혈 보존 시장

제10장 기타 지역(ROW)의 제대혈 보존 시장

• ROW의 제대혈 보존 시장 : 종류별
• ROW의 제대혈 보존 시장 : 용도별
• 중동의 제대혈 보존 시장
• 남미의 제대혈 보존 시장
• 아프리카의 제대혈 보존 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계의 제대혈 보존 시장 최신 동향
• 전략 분석

제13장 밸류체인 전반에 걸친 주요 기업 개요

• 경쟁 분석 : 개요
• CCBC
• CBR
• ViaCord
• Esperite
• Vcanbio
• Boyalife
• LifeCell
• Crioestaminal
• Cryocord
• Cryo-cell

제14장 부록

영문목차

The future of the global cord blood storage market looks promising with opportunities in the diseases therapy and healthcare markets. The global cord blood storage market is expected to grow with a CAGR of 6.8% from 2025 to 2031. The major drivers for this market are the increasing awareness about stem cell therapy, the rising adoption of personalized medicine solutions, and the growing demand for long-term medical preservation.

• Lucintel forecasts that, within the type category, long term storage is expected to witness higher growth over the forecast period.
• Within the application category, diseases therapy is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Cord Blood Storage Market

The cord blood storage market is experiencing rapid growth driven by increasing awareness of the medical benefits of cord blood, technological advancements, and expanding applications in regenerative medicine. As parents and healthcare providers recognize the potential of cord blood for treating various diseases, the market is evolving with innovative storage solutions and regulatory support. These developments are shaping a competitive landscape that emphasizes safety, accessibility, and technological integration. The following key trends highlight the major shifts influencing this market, reflecting its trajectory toward broader adoption and improved patient outcomes.

• Growing Awareness and Adoption: Increasing public and healthcare provider awareness about the medical benefits of cord blood storage is driving market growth. Educational campaigns and success stories of treatments using cord blood are encouraging more parents to opt for storage. This trend is supported by expanding clinical research demonstrating the potential of cord blood in treating conditions like leukemia, anemia, and immune disorders. As a result, demand for private and public banking services is rising, making cord blood storage a more mainstream healthcare practice.
• Technological Advancements in Storage and Processing: Innovations in cryopreservation techniques and processing methods are enhancing the viability and longevity of stored cord blood. Improved methods reduce cell damage during freezing and thawing, increasing the success rate of transplants. Automated processing systems and better storage containers are also reducing contamination risks. These technological improvements are making cord blood banking more reliable and cost-effective, thereby encouraging more families and healthcare providers to invest in storage solutions.
• Expansion of Therapeutic Applications: The scope of diseases treatable with cord blood is broadening beyond hematological disorders to include regenerative medicine applications such as neurological disorders, cerebral palsy, and diabetes. Advances in stem cell research are unlocking new therapeutic potentials, which in turn boost demand for stored cord blood. This expansion is attracting investments and fostering collaborations between biotech firms and healthcare institutions, further accelerating market growth and diversifying the use cases for stored cord blood.
• Regulatory Framework and Standardization: Governments and regulatory bodies are establishing clearer guidelines and standards for cord blood banking, ensuring safety, quality, and ethical practices. These regulations help build consumer confidence and facilitate international collaborations. Standardization of processing and storage protocols also ensures consistency across banks, which is crucial for clinical success. Enhanced regulatory oversight is fostering a more trustworthy market environment, encouraging more families to consider cord blood banking as a safe and reliable option.
• Increasing Investment and Market Competition: The market is witnessing rising investments from private equity, biotech firms, and healthcare providers aiming to expand their services and technological capabilities. This influx of capital is fueling innovation, infrastructure development, and marketing efforts. Competition among service providers is leading to improved pricing, service quality, and customer engagement strategies. As a result, the market is becoming more dynamic, with new entrants and expanded offerings, ultimately benefiting consumers through better access and options.

In summary, these trends are collectively transforming the cord blood storage market by making it more innovative, reliable, and accessible. The increasing awareness, technological progress, broader therapeutic applications, regulatory support, and investment influx are driving sustained growth. These developments are not only expanding the market size but also enhancing the quality and safety of cord blood banking, positioning it as a vital component of modern healthcare and regenerative medicine.

Recent Developments in the Cord Blood Storage Market

The cord blood storage market has experienced significant growth driven by increasing awareness of stem cell therapies, technological advancements, and expanding applications in regenerative medicine. As healthcare providers and consumers recognize the potential of cord blood for treating various diseases, the market is evolving rapidly. Innovations in collection, processing, and storage techniques are enhancing the viability and safety of stored cord blood. Additionally, regulatory frameworks and partnerships are shaping market dynamics. These developments collectively influence market growth, accessibility, and the overall landscape, making it a crucial area within the broader biotech and healthcare sectors.

• Technological Advancements: Improved processing and cryopreservation techniques have increased the viability and longevity of stored cord blood, boosting confidence among consumers and healthcare providers. These innovations reduce contamination risks and enhance cell recovery rates, leading to better treatment outcomes and expanding the market's scope.
• Regulatory Developments: Governments and regulatory bodies are establishing clearer guidelines for cord blood banking, ensuring safety, quality, and ethical standards. These regulations foster trust among consumers and facilitate international collaborations, thereby expanding market reach and standardization.
• Growing Awareness and Adoption: Increased awareness about the therapeutic potential of cord blood stem cells among parents and healthcare professionals has led to higher collection rates. Educational campaigns and success stories are driving demand, especially in emerging markets, contributing to market expansion.
• Strategic Partnerships and Mergers: Major biotech firms and hospitals are forming alliances with cord blood banks to enhance service offerings and research capabilities. These collaborations facilitate innovation, improve infrastructure, and increase market penetration, fostering overall industry growth.
• Expansion of Applications: The scope of cord blood use is broadening beyond hematopoietic stem cell transplants to include regenerative medicine, autoimmune diseases, and personalized therapies. This diversification is attracting new investors and increasing market size, with future growth prospects looking promising.

In summary, recent developments such as technological innovations, regulatory clarity, increased awareness, strategic collaborations, and expanding applications are collectively propelling the cord blood storage market forward. These factors are enhancing market stability, expanding access, and fostering innovation, ultimately contributing to a robust growth trajectory in the healthcare and biotech sectors.

Strategic Growth Opportunities in the Cord Blood Storage Market

The cord blood storage market is experiencing rapid growth driven by increasing awareness of stem cell therapies, advancements in preservation techniques, and expanding applications in regenerative medicine. As healthcare providers and consumers recognize the potential of cord blood for treating various diseases, the market is poised for significant development. Key applications such as medical research, transplantation, regenerative medicine, and personalized medicine are fueling this expansion. Strategic opportunities across these sectors can unlock new revenue streams, improve patient outcomes, and foster innovation. Understanding these growth avenues is essential for stakeholders aiming to capitalize on emerging trends and maintain competitive advantage in this evolving landscape.

• Advancing scientific understanding : The storage of cord blood enables researchers to explore new treatments and develop innovative therapies, driving market growth and expanding the scope of medical research.
• Increasing demand for stem cell transplants : The rising prevalence of blood disorders and cancers boosts demand for stored cord blood, making it a vital resource for transplant procedures and improving patient survival rates.
• Promoting tissue repair and regeneration : Cord blood's rich stem cell content supports regenerative therapies, opening new avenues for treating injuries and degenerative diseases, thereby expanding market applications.
• Tailoring treatments to individual patients : The ability to store a patient's own cord blood facilitates personalized therapies, enhancing treatment efficacy and reducing rejection risks, which boosts market adoption.
• Improving preservation and processing techniques : Advances in cryopreservation and processing methods increase the viability and usability of stored cord blood, making it more attractive to consumers and healthcare providers.

In summary, these growth opportunities are significantly impacting the cord blood storage market by broadening its applications, increasing demand, and fostering innovation. They are driving market expansion, attracting investments, and enhancing the potential for personalized and regenerative therapies, ultimately transforming healthcare outcomes and positioning the market for sustained growth.

Cord Blood Storage Market Driver and Challenges

The cord blood storage market is influenced by a variety of technological, economic, and regulatory factors that shape its growth and development. Advances in medical technology and increasing awareness about the benefits of cord blood banking are driving market expansion. Economic factors such as rising healthcare expenditure and increasing disposable incomes enable more families to consider private storage options. Regulatory frameworks and government initiatives also play a crucial role in shaping market dynamics by establishing standards and encouraging public banking. However, the market faces challenges related to high costs, ethical concerns, and regulatory complexities that could hinder growth. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape effectively.

The factors responsible for driving the cord blood storage market include:

• Technological Advancements: The development of improved cryopreservation techniques and faster processing methods has enhanced the viability and safety of stored cord blood. Innovations such as automated processing systems and better stem cell extraction methods increase the efficiency and success rates of stem cell transplants. These technological improvements make private and public banking more reliable, encouraging more parents to opt for cord blood storage. As research continues to evolve, the potential for expanded therapeutic applications further boosts market growth, attracting investments and increasing consumer confidence.
• Rising Awareness and Education: Increasing awareness about the potential health benefits of cord blood stem cells, including their use in treating blood disorders and immune deficiencies, is a significant driver. Educational campaigns by healthcare providers and industry players inform expectant parents about the advantages of banking cord blood. This heightened awareness leads to higher enrollment rates in private banks and increased support for public banking initiatives. As more people understand the importance of early collection and storage, demand for cord blood banking services continues to grow, fueling market expansion.
• Growing Healthcare Expenditure: The rise in healthcare spending globally, especially in emerging economies, supports the adoption of advanced medical services like cord blood banking. Higher disposable incomes enable families to afford private storage options, which are often costly. Additionally, increased investment by healthcare providers and governments in stem cell research and regenerative medicine enhances the availability and quality of cord blood banking services. This economic growth facilitates broader access and encourages innovation, thereby expanding the market's reach and potential.
• Regulatory Support and Government Initiatives: Governments and regulatory bodies are implementing policies to promote cord blood banking, including funding for public banks and establishing standards for private banks. Such initiatives ensure safety, quality, and ethical compliance, which build consumer trust. Public awareness campaigns and subsidies further incentivize participation in cord blood banking programs. These regulatory frameworks create a conducive environment for market growth by ensuring quality assurance and expanding access, especially in regions where healthcare infrastructure is developing.
• Increasing Incidence of Blood Disorders: The rising prevalence of blood-related diseases such as leukemia, lymphoma, and anemia increases the demand for stem cell transplants, which can be sourced from cord blood. As the incidence of these conditions grows, so does the need for readily available, compatible stem cell sources. Cord blood offers a less invasive collection process and a higher tolerance for HLA mismatches, making it an attractive option for treatment. This medical necessity directly fuels the demand for cord blood storage services, contributing to market growth.

The challenges facing this cord blood storage market include:

• High Cost of Storage: The expenses associated with private cord blood banking, including collection, processing, and long-term storage fees, are significant barriers for many families. These costs can range from several thousand to tens of thousands of dollars over the years, limiting accessibility. The high price point restricts market growth primarily to affluent populations, creating disparities in access. Additionally, the uncertain future therapeutic use of stored cord blood raises questions about cost-effectiveness, which may deter some consumers from investing in private storage options.
• Ethical and Legal Concerns: Ethical debates surrounding the collection and use of cord blood, especially in private banking, pose challenges. Concerns about commodification of human tissues and the potential for misuse or unethical practices can hinder consumer trust. Legal regulations vary across regions, complicating compliance for international banks and limiting market expansion. Ethical issues also include debates over public versus private banking priorities and the equitable distribution of resources, which influence policy-making and consumer perceptions.
• Limited Public Awareness and Infrastructure: Despite growing interest, many expectant parents remain unaware of cord blood banking options or the benefits it offers. This lack of awareness hampers market growth, especially in developing regions. Additionally, inadequate infrastructure, such as limited public banks and processing facilities, restricts access and availability. The absence of standardized protocols and insufficient healthcare provider training further impede widespread adoption. Overcoming these barriers requires concerted efforts in education, infrastructure development, and policy support.

In summary, the cord blood storage market is driven by technological innovations, increased awareness, economic growth, supportive regulations, and rising disease prevalence. However, high costs, ethical concerns, and infrastructural limitations present significant hurdles. These factors collectively influence market dynamics, with growth prospects hinging on addressing challenges through policy, innovation, and education. The market's future will depend on balancing technological progress and ethical considerations while making services more accessible and affordable for a broader population.

List of Cord Blood Storage Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cord blood storage companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cord blood storage companies profiled in this report include-

• CCBC
• CBR
• ViaCord
• Esperite
• Vcanbio
• Boyalife
• LifeCell
• Crioestaminal
• Cryocord
• Cryo-cell

Cord Blood Storage Market by Segment

The study includes a forecast for the global cord blood storage market by type, application, and region.

Cord Blood Storage Market by Type [Value from 2019 to 2031]:

• Long Term Storage
• Short-Term Storage

Cord Blood Storage Market by Application [Value from 2019 to 2031]:

• Diseases Therapy
• Healthcare

Cord Blood Storage Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Cord Blood Storage Market

The cord blood storage market has experienced significant growth driven by increasing awareness of stem cell therapies, advancements in preservation technologies, and expanding healthcare infrastructure worldwide. Countries are investing in research and development to improve storage methods and expand access to cord blood banking. Regulatory frameworks are evolving to ensure safety and quality, while consumer demand for regenerative medicine options continues to rise. This dynamic landscape reflects a global shift towards personalized medicine and early intervention strategies, with key markets adopting innovative solutions to meet the growing need for reliable cord blood storage services.

• United States: The US market has seen rapid growth due to high awareness, advanced healthcare infrastructure, and supportive regulations. Leading companies are investing in innovative cryopreservation techniques and expanding public and private banking options. Recent developments include increased government funding for stem cell research and collaborations with biotech firms to enhance storage safety and efficacy. The adoption of new consent protocols and data privacy measures has also strengthened market confidence.
• China: China's cord blood storage market is expanding quickly, driven by government initiatives promoting regenerative medicine and increasing public awareness. Major investments are being made in establishing large-scale banks and improving storage technology. Recent policies support the development of stem cell therapies, leading to a surge in private banking services. The country is also focusing on integrating traditional medicine with modern stem cell applications, fostering innovation in storage and usage.
• Germany: Germany's market is characterized by stringent regulations and high-quality standards, ensuring safe and reliable storage services. Recent advancements include the adoption of automated processing systems and enhanced cryopreservation methods. The country is also investing in research collaborations to explore new therapeutic applications of cord blood. Public awareness campaigns and government incentives have contributed to increased participation in cord blood banking, emphasizing safety and ethical considerations.
• India: India's cord blood storage market is witnessing rapid growth due to rising awareness, increasing healthcare access, and affordability. Recent developments include the establishment of numerous private banks and government initiatives to promote stem cell research. Technological advancements such as improved cryopreservation techniques are being adopted to enhance storage longevity. The government's focus on expanding healthcare infrastructure and encouraging public-private partnerships is expected to further boost market growth.
• Japan: Japan's market is driven by a strong focus on research and innovation, with significant investments in stem cell therapy development. Recent advancements include the integration of cord blood banking with regenerative medicine centers and the adoption of advanced storage technologies. Regulatory frameworks are being updated to facilitate clinical applications, and public awareness campaigns are promoting the benefits of cord blood banking. Japan continues to lead in developing novel therapies utilizing stored cord blood, fostering a robust and innovative market environment.

Features of the Global Cord Blood Storage Market

• Market Size Estimates: Cord blood storage market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Cord blood storage market size by type, application, and region in terms of value ($B).
• Regional Analysis: Cord blood storage market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cord blood storage market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cord blood storage market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cord blood storage market by type (long term storage and short-term storage), application (diseases therapy and healthcare), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Cord Blood Storage Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Long Term Storage : Trends and Forecast (2019-2031)
• 4.4 Short-Term Storage : Trends and Forecast (2019-2031)

5. Global Cord Blood Storage Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Diseases Therapy : Trends and Forecast (2019-2031)
• 5.4 Healthcare : Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Cord Blood Storage Market by Region

7. North American Cord Blood Storage Market

• 7.1 Overview
• 7.2 North American Cord Blood Storage Market by Type
• 7.3 North American Cord Blood Storage Market by Application
• 7.4 The United States Cord Blood Storage Market
• 7.5 Canadian Cord Blood Storage Market
• 7.6 Mexican Cord Blood Storage Market

8. European Cord Blood Storage Market

• 8.1 Overview
• 8.2 European Cord Blood Storage Market by Type
• 8.3 European Cord Blood Storage Market by Application
• 8.4 German Cord Blood Storage Market
• 8.5 French Cord Blood Storage Market
• 8.6 Italian Cord Blood Storage Market
• 8.7 Spanish Cord Blood Storage Market
• 8.8 The United Kingdom Cord Blood Storage Market

9. APAC Cord Blood Storage Market

• 9.1 Overview
• 9.2 APAC Cord Blood Storage Market by Type
• 9.3 APAC Cord Blood Storage Market by Application
• 9.4 Chinese Cord Blood Storage Market
• 9.5 Indian Cord Blood Storage Market
• 9.6 Japanese Cord Blood Storage Market
• 9.7 South Korean Cord Blood Storage Market
• 9.8 Indonesian Cord Blood Storage Market

10. ROW Cord Blood Storage Market

• 10.1 Overview
• 10.2 ROW Cord Blood Storage Market by Type
• 10.3 ROW Cord Blood Storage Market by Application
• 10.4 Middle Eastern Cord Blood Storage Market
• 10.5 South American Cord Blood Storage Market
• 10.6 African Cord Blood Storage Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global Cord Blood Storage Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 CCBC
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 CBR
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 ViaCord
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Esperite
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vcanbio
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Boyalife
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 LifeCell
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Crioestaminal
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Cryocord
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Cryo-cell
  • Company Overview
  • Cord Blood Storage Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us